Login / Signup

Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.

Francisco José RomeoIgnacio Miguel SeropianJuan Guido ChiabrandoJuan Valle RaleighMaximiliano SmietnianskyMariela CalMariano FalconiVadim KotowiczCarla Romina AgatielloDaniel Horacio Berrocal
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
CA-125, a tumor biomarker, outperformed frailty for predicting the primary endpoint within the first year after TAVR.
Keyphrases
  • transcatheter aortic valve replacement
  • patients undergoing
  • aortic stenosis
  • aortic valve
  • community dwelling
  • left ventricular
  • ejection fraction